Showing results (1491-1500 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|June 1, 1988
Acute leukemia occurring after radiotherapy and chemotherapy with a nitrosourea, PCNUK V Shepard, R Larson, M M Le Beau, et al.
Investigational New Drugs|June 1, 1988
PCNU: phase II evaluation in advanced colorectal carcinomaR Pazdur, M K Samson, L H Baker
Investigational New Drugs|November 9, 2019
Anticancer activities of vitamin K3 analoguesKevin W Wellington, Vincent Hlatshwayo, Natasha I Kolesnikova, et al.
Investigational New Drugs|September 1, 1988
Phase II study of flutamide in patients with metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group studyD J Perrault, D M Logan, D J Stewart, et al.
Investigational New Drugs|February 3, 2020
Metabolomic profiling to evaluate the efficacy of proxalutamide, a novel androgen receptor antagonist, in prostate cancer cellsFeng Qu, Yue Gu, Qizhi Wang, et al.
Investigational New Drugs|February 6, 2020
Phase 1 study of the MDM2 antagonist RO6839921 in patients with acute myeloid leukemiaGeoffrey L Uy, Sarit Assouline, Anne-Marie Young, et al.
Investigational New Drugs|May 17, 2022
A phase Ib dose escalation study of oral monotherapy with KX2-391 in elderly patients with acute myeloid leukemiaMargaret T Kasner, Molly B Halloran, Jonathan Pan, et al.
Investigational New Drugs|May 13, 2022
A lung adenocarcinoma patient harboring MET c. 3028 + 2 T >A variant sensitive to crizotinib treatmentRui Jiang, Dongguang Wei, Yuan Tan, et al.
Investigational New Drugs|May 7, 2022
Identifification of a novel LDLR-RET Fusion in Lung AdenocarcinomaGuanglin Shi, Yuyan Luo, Zhaonan Yu, et al.
Investigational New Drugs|January 10, 2018
A phase 1 study of PARP-inhibitor ABT-767 in advanced solid tumors with BRCA1/2 mutations and high-grade serous ovarian, fallopian tube, or primary peritoneal cancerDiane A J van der Biessen, Jourik A Gietema, Maja J A de Jonge, et al.
Pageof 372